Safety and efficacy of a COVID-19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open-label, controlled trial.

Autor: Delgado-Enciso I; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México.; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, México., Paz-Garcia J; Department of Internal Medicine and Surgery, Union Hospital Center, Villa de Álvarez, Colima 28970, México., Barajas-Saucedo CE; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Mokay-Ramírez KA; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Meza-Robles C; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México.; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, México., Lopez-Flores R; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, México., Delgado-Machuca M; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, México., Murillo-Zamora E; Department of Research, General Hospital of Zone No. 1 and Family Medicine Unit No. 19 IMSS, Villa de Alvarez, Colima 28984, México., Toscano-Velazquez JA; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Delgado-Enciso J; Department of Research, Foundation for Cancer Ethics, Education and Research of the Cancerology State Institute, Colima 28085, México., Melnikov V; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Walle-Guillen M; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México.; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, México., Galvan-Salazar HR; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México.; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, México., Delgado-Enciso OG; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México.; Department of Research, Foundation for Cancer Ethics, Education and Research of the Cancerology State Institute, Colima 28085, México., Cabrera-Licona A; Department of Research, Esteripharma S.A. de C.V., Ciudad de México 03100, México., Danielewicz-Mata EJ; COVID-19 Respiratory Care Clinic INSABI Poliforum, Tuxtla Gutierrez, Chiapas 29040, México., Mandujano-Diaz PJ; COVID-19 Respiratory Care Clinic INSABI Poliforum, Tuxtla Gutierrez, Chiapas 29040, México., Guzman-Esquivel J; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México.; Department of Research, Foundation for Cancer Ethics, Education and Research of the Cancerology State Institute, Colima 28085, México., Montes-Galindo DA; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México.; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, México., Perez-Martinez H; COVID-19 Respiratory Care Clinic INSABI Poliforum, Tuxtla Gutierrez, Chiapas 29040, México., Jimenez-Villegaz JM; COVID-19 Respiratory Care Clinic INSABI Poliforum, Tuxtla Gutierrez, Chiapas 29040, México., Hernandez-Rangel AE; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Montes-Diaz P; Private Medical Office Xochitepec, Xochitepec, Morelos 62795, México., Rodriguez-Sanchez IP; Laboratory of Molecular and Structural Physiology, School of Biological Sciences, Universidad Autónoma de Nuevo León, San Nicolas de los Garza, Nuevo León 66455, México., Martinez-Fierro ML; Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas 98160, México., Garza-Veloz I; Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas 98160, México., Tiburcio-Jimenez D; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Zaizar-Fregoso SA; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Gonzalez-Alcaraz F; COVID-19 Respiratory Care Clinic INSABI Poliforum, Tuxtla Gutierrez, Chiapas 29040, México., Gutierrez-Gutierrez L; COVID-19 Respiratory Care Clinic INSABI Poliforum, Tuxtla Gutierrez, Chiapas 29040, México., Diaz-Lopez L; COVID-19 Respiratory Care Clinic INSABI Poliforum, Tuxtla Gutierrez, Chiapas 29040, México., Ramirez-Flores M; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Guzman-Solorzano HP; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Gaytan-Sandoval G; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, México., Martinez-Perez CR; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, México., Espinoza-Gómez F; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Rojas-Larios F; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Hirsch-Meillon MJ; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, México., Baltazar-Rodriguez LM; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Barrios-Navarro E; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Oviedo-Rodriguez V; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, México., Mendoza-Hernandez MA; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Prieto-Diaz-Chavez E; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México., Paz-Michel BA; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, México.; Department of Research, Esteripharma S.A. de C.V., Ciudad de México 03100, México.

Publikováno v: Experimental and therapeutic medicine [Exp Ther Med] 2021 Sep; Vol. 22 (3), pp. 915. Date of Electronic Publication: 2021 Jun 29.

Decreased biochemical progression in patients with castration-resistant prostate cancer using a novel mefenamic acid anti-inflammatory therapy: A randomized controlled trial.

Autor: Guzman-Esquivel J; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.; Department of Research, General Hospital of Zone No. 1 IMSS, Villa de Alvarez, Colima 28983, Mexico., Mendoza-Hernandez MA; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico., Tiburcio-Jimenez D; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico., Avila-Zamora ON; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico., Delgado-Enciso J; Department of Research, Foundation for Cancer Ethics, Education and Research of The Cancerology State Institute, Colima 28085, Mexico., De-Leon-Zaragoza L; Department of Research, General Hospital of Zone No. 1 IMSS, Villa de Alvarez, Colima 28983, Mexico.; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico., Casarez-Price JC; Department of Research, General Hospital of Zone No. 1 IMSS, Villa de Alvarez, Colima 28983, Mexico.; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico., Rodriguez-Sanchez IP; Molecular and Structural Physiology Laboratory, School of Biological Sciences, Autonomous University of Nuevo León, Monterrey, Nuevo León 64460, Mexico., Martinez-Fierro ML; Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas, Zacatecas 98160, Mexico., Meza-Robles C; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico., Barocio-Acosta A; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico., Baltazar-Rodriguez LM; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico., Zaizar-Fregoso SA; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico., Plata-Florenzano JE; Department of Research, General Hospital of Zone No. 1 IMSS, Villa de Alvarez, Colima 28983, Mexico.; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico., Delgado-Enciso I; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.

Publikováno v: Oncology letters [Oncol Lett] 2020 Jun; Vol. 19 (6), pp. 4151-4160. Date of Electronic Publication: 2020 Apr 03.

Are the CYP2D6*G and MDR1, 3435T Alleles Associated with the Risk of Ulcerative Colitis in Iranian Population?

Autor: Ramirez Garcia SA; University of the Sierra Southern, SUNEO, Miahuatlán de Porfirio Díaz, Oaxaca, México.; Faculty of Medicine of the University of Colima, Colima, Mexico., Flores Alvarado LJ; Laboratory of Biochemistry, Department of Molecular and Genomic Biology, University Center of Health Sciences, University of Guadalajara, Jalisco, Mexico., Baltazar Rodriguez LM; Institute of Human Genetics Enrique Corona Rivera, Department of Molecular and Genomic Biology, University Center of Health Sciences, University of Guadalajara, Jalisco, Mexico., Garcia Cruz D; Faculty of Medicine of the University of Colima, Colima, Mexico.

Publikováno v: Archives of Iranian medicine [Arch Iran Med] 2019 Nov 01; Vol. 22 (11), pp. 680-681. Date of Electronic Publication: 2019 Nov 01.

HPV 16 and 18 viral loads are greater in patients with high-grade cervical epithelial lesions.

Autor: Ramirez-Flores M, Delgado-Enciso I, Fernandez-Salinas ARG, Valdez-Velazquez LL, Guzman-Esquivel J, Baltazar-Rodriguez LM

Publikováno v: European journal of gynaecological oncology [Eur J Gynaecol Oncol] 2016; Vol. 37 (5), pp. 644-648.

The protective effect of peanut, walnut, and almond consumption on the development of breast cancer.

Autor: Soriano-Hernandez AD; Instituto Estatal de Cancerologia, Servicios de Salud del Estado de Colima, University of Colima, Colima, Mexico., Madrigal-Perez DG, Galvan-Salazar HR, Arreola-Cruz A, Briseño-Gomez L, Guzmán-Esquivel J, Dobrovinskaya O, Lara-Esqueda A, Rodríguez-Sanchez IP, Baltazar-Rodriguez LM, Espinoza-Gomez F, Martinez-Fierro ML, de-Leon-Zaragoza L, Olmedo-Buenrostro BA, Delgado-Enciso I

Publikováno v: Gynecologic and obstetric investigation [Gynecol Obstet Invest] 2015; Vol. 80 (2), pp. 89-92. Date of Electronic Publication: 2015 Jul 10.